Efficacy and Safety of Oral Bosentan on Healing/Prevention of Digital (Finger) Ulcers in Patients With Scleroderma

NCT00077584 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

188

Enrollment

INDUSTRY

Sponsor class

Conditions

Digital Ulcers
Systemic Sclerosis

Interventions

DRUG: Bosentan 62.5 mg
DRUG: Bosentan 125 mg
DRUG: Placebo

Sponsor

Actelion